Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib Trial.

ficerafusp alfa (BCA101) - Bicara Therapeutics

Keytruda (pembrolizumab) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/42102329

Alberto Hernando-Calvo; Assuntina G Sacco; Brenda C O'Connell; Christine H Chung; Dan P Zandberg; David Bohr; David Raben; Deborah J Wong; Emrullah Yilmaz; Eric Sherman; Glenn J Hanna; Jeltje Schulten; John Kaczmar; Rachel L Salazar; Ralf D Reiners

May 9, 2026